Pharmafile Logo
Pharmafocus logo
Advanced Search

Arixtra

Showing 3 posts of 3 posts found.

GSK image

GSK mulling sales of thrombosis brands and facility to Aspen

June 24, 2013
Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen

GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …

News

GSK’s Arixtra set for expanded licence

July 26, 2010
Sales and Marketing Arixtra, Avandia, GlaxoSmithKline, rotarix

GlaxoSmithKline is set to receive a green light to use its anti-clotting drug Arixtra to prevent spontaneous superficial-vein thrombosis (SVT). …

News

Arixtra approved for new blood clot indication

July 20, 2005
Sales and Marketing Arixtra, GlaxoSmithKline

GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025